MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?

por de la Torre, Rafael, Yubero-Lahoz, Samanta, Pardo-Lozano, Ricardo, Farré, Magí
Publicado 2012

Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT)

por Pardo-Lozano, Ricardo, Farré, Magí, Yubero-Lahoz, Samanta, O’Mathúna, Brian, Torrens, Marta, Mustata, Cristina, Pérez-Mañá, Clara, Langohr, Klaus, Cuyàs, Elisabet, Carbó, Marcel·lí, de la Torre, Rafael
Publicado 2012